Ranolazine Tablet, Extended Release
Product Images NDC 63629-4874

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 63629-4874). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (2c72dbc3 5385 4706 B5fd 841d4b70a26f 01)

Chemical structure diagram of the active ingredient Ranolazine, showing the molecular arrangement including aromatic rings, nitrogen atoms, hydroxyl groups, and methoxy substituents.*

FDA Label Image

Label (Lbl636294874)

The label for Ranolazine Extended-Release Tablets features a 500 mg strength prominently within an orange-bordered box. The NDC 63629-4874-1 is displayed at the top. The label includes dosage form (extended-release tablets) and quantity (60 tablets). It states the product is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Zydus Lifesciences Ltd. Additional storage and usage instructions, QR codes, and barcodes are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.